Ibritumomab Tiuxetan and Rajani
Determining the interaction of Ibritumomab Tiuxetan and Rajani and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: drospirenone / ethinyl estradiol / levomefolate calcium
Brand name: Beyaz, Rajani, Safyral, Tydemy
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Raloxifene
- Ibritumomab Tiuxetan-Raloxifene Hydrochloride
- Ibritumomab Tiuxetan-Raloxifene Hydrochloride Tablets
- Ibritumomab Tiuxetan-Raltegravir
- Ibritumomab Tiuxetan-Raltegravir Chewable Tablets
- Ibritumomab Tiuxetan-Raltegravir Potassium
- Rajani-Ibrutinib
- Rajani-Ibrutinib Capsules
- Rajani-Ibrutinib Tablets
- Rajani-Ibu
- Rajani-IBU Tablets
- Rajani-Ibu-2